• Electronic White Blood Cell Tracker Developed For Near-Patient Testing

    Feb 21 | Diagnostics World | A revolution is underway in the diagnostics world that is reminiscent of what transpired in the computing field before the advent of PCs and smartphones. The unimagined possibilities of today will come from democratizing technology so that instead of sending patients to the lab, the lab will get sent to patients—and, ultimately, be available to them in the form of at-home testing kits. More
  • Measuring Sleep Apnea Severity With Sweat

    Feb 20 | Diagnostics World | Researchers in Spain are advocating the use of sweat in metabolomics studies to measure the severity of sleep apnea. It’s an ideal alternative to blood and urine because the sampling is noninvasive and accessible, and the biofluid doesn’t require much manipulation by the test operator that can introduce variability. More
  • Texas Building First End-To-End Wastewater Pathogen Monitoring System

    Feb 15 | Diagnostics World | In the future, it may be possible for people to get a read on viruses circulating in their neighborhood in the same way they now do to assess current weather conditions before hitting the road. The means would be some sort of digitized community health report, an early version of which is already being produced for 10 cities across Texas. More
  • Study Establishes ENPP1 As A Biomarker For Immunotherapy Benefit

    Feb 13 | Diagnostics World | Researchers in California have shown that breast cancer patients with RNA expression levels of ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) in the bottom 50th percentile can confidently be treated with Keytruda (pembrolizumab) as well as surgery. Their cancer would have a zero percent chance of metastasizing in seven years. More
  • Five Health Systems Picking Dandelion Health To Advance Clinical AI

    Feb 08 | Diagnostics World | If artificial intelligence (AI) is to be as insightful as possible in advancing human health, it is not enough to have a patchwork of out-of-context data from which to draw conclusions. That is unfortunately the current situation and at the cost of lost opportunities to better treat patients, identify early biomarkers of disease, and recognize the right endpoints in clinical trials—not to mention eradicating existing biases against marginalized groups of people. More
  • Novel NGS-Based Assay Has Seemingly Limitless Virus Detection Potential

    Feb 07 | Diagnostics World | Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection. More
  • Protein Signatures Of Organ Aging Could Aid Disease Prevention Efforts

    Feb 06 | Diagnostics World | Stanford Medicine investigators are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age. Among the potential applications are screening people for conditions such as heart failure and Alzheimer’s disease, personalizing the intervention they’re prescribed, and signaling sooner the efficacy of investigational drugs based on how well they rejuvenate certain organs. More
  • Oxford Nanopore Expands Respiratory Pilot Program, Imagine Pharma Launches Foundation, Collaborations for Rare Diseases, More

    Jan 31 | Diagnostics World | Oxford Nanopore Technologies and Guy’s and St Thomas’ NHS Foundation Trust have collaborated and successfully completed a pilot program meant to deliver a respiratory metagenomics service with an integrated respiratory infection and biosecurity application; Imagine Pharma announced the formation of The Imagine Pharma Foundation, a private, not-for-profit charitable organization dedicated to advancing metabolic research to significantly impact the lives of those affected by diabetes, with a particular emphasis on serving veterans; DNAnexus and TMA Precision Health announced a collaboration to advance basic and translational research for patients who have a rare disease; more. More
  • Follow the Money: Cleveland Diagnostics Expands Development, Depression Treatment Implant Device, Major Liver Cirrhosis Study, More

    Jan 30 | Diagnostics World | Cleveland Diagnostics intends to accelerate the company’s commercial and corporate development goals; Motif Neurotech has secured funding for the development of lead product, DOT microstimulator, to treat depression; Newcastle University, University of Edinburgh, and Boehringer Ingelheim will begin the most extensive clinical study into liver cirrhosis ever to better understand NASH cirrhosis and identifying translational biomarkers; more. More
  • New Patient Scoring Method To Enable Precision Medicine For Chronic Diseases

    Jan 25 | Diagnostics World | In a big advance for precision medicine, researchers in Australia have developed a genetic biomarker of people’s response to sodium reduction. It is often but not always the case that modifying sodium levels lowers blood pressure by reducing the fluid volume of blood in the cardiovascular system, and knowing in advance how patients will respond could help eliminate the “treatment odyssey” that many of them are experiencing. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more